Dylan Lee is currently the Director of FP&A at Allogene Therapeutics, having advanced through various leadership roles within the company since 2022. Prior to this, Dylan held financial positions at Nektar Therapeutics, including Manager and Senior Financial Analyst, and worked at Old Navy as a Senior Analyst in Company Planning. Dylan's earlier experience includes serving as Assurance Senior Associate and Assurance Associate at PwC from 2016 to 2019. Dylan earned a Master’s Degree in Accounting from the University of California, Davis, and a Bachelor’s Degree in Chinese from the University of California, Berkeley.